AUROPHARMA2020-01-012020-03-31in-bse-fin:OneOperatingExpenses01Member AUROPHARMA2020-01-012020-03-31in-bse-fin:OneOperatingExpenses02Member AUROPHARMA2020-01-012020-03-31in-bse-fin:FourOperatingExpenses01Member AUROPHARMA2020-01-012020-03-31in-bse-fin:FourOperatingExpenses02Member AUROPHARMA2020-01-012020-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AUROPHARMA2020-01-012020-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AUROPHARMA2020-01-012020-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member AUROPHARMA2020-01-012020-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AUROPHARMA 2019-04-01 2020-03-31 2020-05-27 INR Lakhs Yearly Single segment Pharmaceutical Products 2020-01-01 2020-03-31 Audited Consolidated 61584300000.00 325900000.00 61910200000.00 20379800000.00 5132400000.00 -478500000.00 8643300000.00 318300000.00 2324100000.00 14745100000.00 51064500000.00 10845700000.00 122500000.00 10968200000.00 3295500000.00 -1010300000.00 2285200000.00 0.00 8683000000.00 0.00 0.00 0.00 -193100000.00 8489900000.00 1487400000.00 9977300000.00 8498300000.00 -8400000.00 9985700000.00 -8400000.00 585900000.00 1 14.50 14.50 0.00 0.00 14.50 14.50 Single segment 2019-04-01 2020-03-31 Audited Consolidated 230985000000.00 862000000.00 231847000000.00 77249800000.00 21121100000.00 -1018600000.00 32191800000.00 1597700000.00 9667100000.00 53194900000.00 194003800000.00 37843200000.00 -261300000.00 37581900000.00 9569500000.00 -434400000.00 9135100000.00 0.00 28446800000.00 0.00 0.00 0.00 -151700000.00 28295100000.00 2871200000.00 31166300000.00 28309700000.00 -14600000.00 31180900000.00 -14600000.00 585900000.00 1 167517900000.00 48.32 48.32 0.00 0.00 48.32 48.32 Foreign exchange loss 261900000.00 Other expenses 14483200000.00 Foreign exchange loss 397000000.00 Other expenses 52797900000.00